KANTONE HOLDING (01059) announces its interim performance with a profit of HK$11.637 million, an increase of 104.8% compared to the same period last year.
Guangdong Investment Limited (01059) announced its performance for the six-month period ending on December 31, 2024. The Group achieved revenue...
KANTONE HOLDING (01059) announced its interim results for the six months ending on December 31, 2024. The group recorded revenue of HKD 72.334 million during the period, a decrease of 13.44% year-on-year. The group also reported a profit of HKD 11.637 million, an increase of 104.8% year-on-year. Earnings per share were 3.72 HK cents.
The announcement stated that the decrease in revenue was due to delays in the acquisition and subsequent fulfillment of emergency service orders in the UK, as well as a decrease in sales at its German subsidiary.
Related Articles
On July 9th, China Alumcan (06898) spent HK$3.85 million to repurchase 5 million shares.
CNSIG Inner Mongolia Chemical Industry (600328.SH): China Salt Alkali Industry obtained the mining rights for natural alkali worth 6.809 billion yuan.
ZHAOKE OPHTH-B(06622): The National Medical Products Administration has accepted the new drug application for NVK002 (0.02% atropine sulfate eye drops) for the treatment of progressive myopia in children.
On July 9th, China Alumcan (06898) spent HK$3.85 million to repurchase 5 million shares.
CNSIG Inner Mongolia Chemical Industry (600328.SH): China Salt Alkali Industry obtained the mining rights for natural alkali worth 6.809 billion yuan.
ZHAOKE OPHTH-B(06622): The National Medical Products Administration has accepted the new drug application for NVK002 (0.02% atropine sulfate eye drops) for the treatment of progressive myopia in children.
RECOMMEND
